Amgen, Inc.

NASDAQ: AMGN
$249.04
-$2.62 (-1.0%)
Closing price July 10, 2020

Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
15 days ago

Major Biotechs Have Short Sellers on the Run
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
1 month ago

Major Biotechs See More Targeted Short Sellers
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Chris Lange
1 month ago

Short Sellers Raise the Stakes in Major Biotechs
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
1 month ago

Why Borrowing $8.5 Billion Won’t Impact Apple Stock
Apple borrowed $8.5 billion Monday in a four-part bond deal. Why? Because right now, money is cheap.
Carl Sullivan
2 months ago

Short Sellers Grow More Selective on Major Biotechs
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
2 months ago

Big Biotechs Scare Off Short Sellers
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Chris Lange
2 months ago

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.
Jon C. Ogg
3 months ago
Last Updated: 3 months ago

Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
3 months ago

Big Biotechs Have Short Sellers Confused
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
3 months ago

Major Biotechs Have Short Sellers Confused
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
4 months ago

15 Top ESG Stocks That Look Undervalued for 2020
With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks appear to be undervalued against the performance of the broader markets.
Jon C. Ogg
4 months ago
Last Updated: 4 months ago

Biotech Short Sellers Focus on a Couple Favorites
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
4 months ago
Last Updated: 4 months ago

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Jon C. Ogg
5 months ago
Last Updated: 5 months ago

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Jon C. Ogg
5 months ago
Last Updated: 5 months ago